Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
31.1M
-
Shares change
-
+3.21M
-
Total reported value, excl. options
-
$605M
-
Value change
-
+$63.9M
-
Put/Call ratio
-
0
-
Number of buys
-
51
-
Number of sells
-
-26
-
Price
-
$19.63
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2018
89 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q2 2018.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.1M shares
of 107M outstanding shares and own 28.97% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (15M shares), BOXER CAPITAL, LLC (1.97M shares), BRIDGER MANAGEMENT, LLC (1.75M shares), Cormorant Asset Management, LP (1.52M shares), BlackRock Inc. (1.31M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.2M shares), VANGUARD GROUP INC (849K shares), CITADEL ADVISORS LLC (829K shares), ORBIMED ADVISORS LLC (775K shares), and DEUTSCHE BANK AG\ (507K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.